JAKAFI - ruxolitinib
Navigation: NDC > Supplier starting with: I > INCYTE CORPORATION| Field | Value |
|---|---|
| NDC Code: | 50881-025 |
| Proprietary Name: | JAKAFI |
| Suffix: | |
| Non-Proprietary Name: | ruxolitinib |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 16-11-2011 |
| Category Name: | NDA |
| Application Number: | NDA202192 |
| Labeler: | INCYTE CORPORATION |
| Substance Name: | RUXOLITINIB |
| Active Numerator Strength: | 25 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| DEA Schedule: |